Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia

by Nabeel Alzahrani, Sameera Al Johani
Published 2013-03-01

MERS-CoV diagnosis: An update

by Sameera Al Johani, Ali H. Hajeer
Published 2016-05-01

Risk factors, antimicrobial susceptibility pattern and patient outcomes of Pseudomonas aeruginosa infection: A matched case-control study

by Fatima A. Alhussain, Nagarajkumar Yenugadhati, Fahad A. Al Eidan, Sameera Al Johani, Motasim Badri
Published 2021-01-01

Burden of non-tuberculous mycobacterial diseases in Saudi Arabian children: The first nationwide experience

by Bright Varghese, Mushira Enani, Mohammed Shoukri, Sameera AlJohani, Sahar AlThawadi, Sahal Al-Hajoj
Published 2019-11-01

Emergence of Rare Species of Nontuberculous Mycobacteria as Potential Pathogens in Saudi Arabian Clinical Setting.

by Bright Varghese, Mushira Enani, Mohammed Shoukri, Sahar AlThawadi, Sameera AlJohani, Sahal Al-Hajoj
Published 2017-01-01

The first Saudi Arabian national inventory study revealed the upcoming challenges of highly diverse non-tuberculous mycobacterial diseases.

by Bright Varghese, Mushira Enani, Mohammed Shoukri, Sameera AlJohani, Hawra Al Ghafli, Sahar AlThawadi, Sahal Al Hajoj
Published 2018-05-01

Demographic risk factors for extra-pulmonary tuberculosis among adolescents and adults in Saudi Arabia.

by Hawra Al-Ghafli, Bright Varghese, Mushira Enani, Abdulrahman Alrajhi, Sameera Al Johani, Ali Albarrak, Sahar Althawadi, Noura Elkizzi, Sahal Al Hajoj
Published 2019-01-01

Impact of Mycobacterium tuberculosis complex lineages as a determinant of disease phenotypes from an immigrant rich moderate tuberculosis burden country

by Bright Varghese, Mushira Enani, Abdulrahman Alrajhi, Sameera Al Johani, Ali Albarak, Sahar Althawadi, Noura Elkhizzi, Hawra AlGhafli, Mohammed Shoukri, Sahal Al - Hajoj
Published 2018-12-01

Evolving sequence mutations in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

by Mohammed Ali AlBalwi, Anis Khan, Mohammed AlDrees, Udayaraja GK, Balavenkatesh Manie, Yaseen Arabi, Ibrahim Alabdulkareem, Sameera AlJohani, Majed Alghoribi, Ahmed AlAskar, Abdulaziz AlAjlan, Ali Hajeer
Published 2020-10-01

A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised contro...

by Mohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, Ahmad Alharbi, Abdulrahman Alsaedy, Adel Alothman, Majed Aljeraisy, Hajar Alqahtani, Marwan Nashabat, Badriah Almutairi, Manar Almaghaslah, Omar Aldibasi, Sameera AlJohani, Abderrezak Bouchama, Yaseen Arabi, Ahmad Alaskar
Published 2020-10-01

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19

by Majed Al-Jeraisy, Ahmed Alaskar, Majid Alshamrani, Mohammad Bosaeed, Ahmad Alharbi, Mohammad Hussein, Mohammed Abalkhail, Khizra Sultana, Abrar Musattat, Hajar Alqahtani, Ebrahim Mahmoud, Adel Alothman, Abdulrahman Alsaedy, Omar Aldibasi, Khalid Alhagan, Abdullah Mohammed Asiri, Sameera AlJohani
Published 2021-04-01

Early identification of pneumonia patients at increased risk of Middle East respiratory syndrome coronavirus infection in Saudi Arabia

by Anwar E. Ahmed, Hamdan Al-Jahdali, Abeer N. Alshukairi, Mody Alaqeel, Salma S. Siddiq, Hanan Alsaab, Ezzeldin A. Sakr, Hamed A. Alyahya, Munzir M. Alandonisi, Alaa T. Subedar, Nouf M. Aloudah, Salim Baharoon, Majid A. Alsalamah, Sameera Al Johani, Mohammed G. Alghamdi
Published 2018-05-01

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

by Yaseen M. Arabi, Adel Alothman, Hanan H. Balkhy, Abdulaziz Al-Dawood, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Abdullah M. Assiri, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Almekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Javed Memon, Yusri Taha, Abdullah Almotairi, Khalid A. Maghrabi, Ismael Qushmaq, Ali Al Bshabshe, Ayman Kharaba, Sarah Shalhoub, Jesna Jose, Robert A. Fowler, Frederick G. Hayden, Mohamed A. Hussein, And the MIRACLE trial group
Published 2018-01-01

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage grou...

by Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Hani A. Aziz Jokhdar, Adel Alothman, Hanan H. Balkhy, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Ziad A. Memish, Sameeh Ghazal, Sarah Al Faraj, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Abdullah Almotairi, Ali Al Bshabshe, Ayman Kharaba, Jesna Jose, Abdulrahman Al Harthy, Mohammed Al Sulaiman, Ahmed Mady, Robert A. Fowler, Frederick G. Hayden, Abdulaziz Al-Dawood, Mohamed Abdelzaher, Wail Bajhmom, Mohamed A. Hussein, and the Saudi Critical Care Trials group
Published 2020-01-01